Integrated infectious disease and substance use disorder treatment for severe injection-related infections: protocol for the randomized controlled HI-SIRI trial.

Saved in:
Bibliographic Details
Title: Integrated infectious disease and substance use disorder treatment for severe injection-related infections: protocol for the randomized controlled HI-SIRI trial.
Authors: Serota DP; Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, 1120 NW 14th St, Suite 851, Miami FL, 33136, USA. dserota@med.miami.edu., Feaster DJ; Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA., Bartholomew TS; Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA., Kapadia SN; Division of Infectious Diseases, Weill Cornell Medicine, New York City, NY, USA.; Department of Population Health Sciences, Weill Cornell Medicine, New York City, NY, USA., Gooden LK; Department of Sociomedical Sciences, Mailman School of Public Health, Columbia University, New York City NY , USA., Murphy SM; Department of Population Health Sciences, Weill Cornell Medicine, New York City, NY, USA., Malik S; Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, 1120 NW 14th St, Suite 851, Miami FL, 33136, USA., Chueng TA; Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, 1120 NW 14th St, Suite 851, Miami FL, 33136, USA., Hernandez S; Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, 1120 NW 14th St, Suite 851, Miami FL, 33136, USA., Rodriguez AE; Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, 1120 NW 14th St, Suite 851, Miami FL, 33136, USA., Alonso E; Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA., Horigian VE; Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA., Walker R; The Emmes Company, Rockville, MD, USA., Matheson T; San Francisco Dept of Public Health, San Francisco, CA, USA., Moran LM; Center for the Clinical Trials Network, National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA., Nelson CM; Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA., Parish C; Department of Sociomedical Sciences, Mailman School of Public Health, Columbia University, New York City NY , USA., Tookes HE; Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, 1120 NW 14th St, Suite 851, Miami FL, 33136, USA., Rio CD; Division of Infectious Diseases , Department of Medicine, Emory University , Atlanta, GA, USA., Metsch LR; Department of Sociomedical Sciences, Mailman School of Public Health, Columbia University, New York City NY , USA.
Source: Addiction science & clinical practice [Addict Sci Clin Pract] 2026 Feb 21; Vol. 21 (1). Date of Electronic Publication: 2026 Feb 21.
Publication Type: Journal Article; Clinical Trial Protocol
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101316917 Publication Model: Electronic Cited Medium: Internet ISSN: 1940-0640 (Electronic) Linking ISSN: 19400632 NLM ISO Abbreviation: Addict Sci Clin Pract Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1940-0640
DOI:10.1186/s13722-026-00654-6